Dr. Todd E. Schlesinger, MD

Dr. Schlesinger practices at Epiphany Dermatology of South Carolina in Austin, Texas.

Dr. Schlesinger's NPI, 1538135280, was assigned on February 23, 2006. Dr. Schlesinger graduated from State University of New York at Buffalo School of Medicine in 1994. Dr. Schlesinger holds South Carolina license 019977.

Dr. Schlesinger's primary practice is Epiphany Dermatology of South Carolina, at 7300 Ranch Rd 2222, Austin, TX 78730 in Travis County. The practice phone is (864) 271-7440.

Dr. Schlesinger's primary practice is Epiphany Dermatology of South Carolina in Austin, Texas. The medical group on file is Epiphany Dermatology. Dmand AI also links Dr. Schlesinger to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schlesinger practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Schlesinger's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Schlesinger is licensed in South Carolina.

CMS data shows 3,962 Medicare services from Dr. Schlesinger across 18 procedure codes in 2024, for 589 Medicare patients. Medicare paid $145,096 for them. Every service was in an office.

CMS counts 589 Medicare patients who saw Dr. Schlesinger in 2024. The largest group is 65 to 74, with 282 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schlesinger's median patient age at 69, with 51% women.

In 2024, Dr. Schlesinger wrote 269 Medicare Part D claims for 159 patients. 98% of them were for generic drugs. CMS names the drug for 176 of them, across 7 drugs with 11 or more claims each, at $4,491 in total drug cost. In 2023, CMS named 151 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Schlesinger for performance year 2024, reported individually. Dr. Schlesinger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 788 procedures of removal of skin lesions by Dr. Schlesinger, more than 91% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Schlesinger to 9 clinical trials. 1 is still active or recruiting. Conditions studied include Eczema, Dermatitis, Atopic and Psoriasis. Eli Lilly and Company sponsors the most, 6. Open Payments lists research payments to Dr. Schlesinger that name 10 trials.

CMS Open Payments shows 2,600 general payments to Dr. Schlesinger from 53 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $454,921. It also lists 41 research payments totaling $40,380 from 2017 to 2025, naming 10 clinical trials.

Dr. Schlesinger graduated from State University of New York at Buffalo School of Medicine in 1994.